Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1982 Mar;47(3):689-96.

The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens

Comparative Study

The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens

A P Johnstone et al. Clin Exp Immunol. 1982 Mar.

Abstract

The proliferative response of lymphocytes from patients with chronic lymphocytic leukaemia (CLL) to the polyclonal activators, phytohaemagglutinin (PHA) and pokeweed mitogen (PWM) correlates inversely with the logarithm of the circulating lymphocyte concentration in vivo (P less than 0.001). This suggests that the response is due primarily to residual normal cells in the circulation. In support of this postulate, dilution of normal cells reproduced the effect and also induced a delayed response to PHA, which is found frequently with CLL lymphocytes. A combination of autoradiography and immunofluorescence microscopy identified both B and T cells in the responding population in similar proportions from both normal and CLL donors. These data demonstrate that the 3H-thymidine assay used in most mitogenic studies is not suitable alone for investigating the functional capacity of leukaemic lymphocytes in CLL and other diseases involving a gross perturbation of lymphocyte populations.

PubMed Disclaimer

References

    1. Proc Soc Exp Biol Med. 1968 Mar;127(3):668-71 - PubMed
    1. Blood. 1969 Aug;34(2):166-78 - PubMed
    1. Cancer Res. 1970 Mar;30(3):717-23 - PubMed
    1. Int Arch Allergy Appl Immunol. 1970;39(5-6):580-6 - PubMed
    1. Lancet. 1972 Jan 29;1(7744):229-33 - PubMed

Publication types

LinkOut - more resources